LIVE NOW: Supreme Court to Hear Immigration, Drug Patent Cases

The Supreme Court of the United States is set to hear oral arguments in two significant cases addressing issues related to immigration authority and pharmaceutical patent law, at 10 a.m. ET on April 29. In Mullin v. Doe and Trump v. Miot, the Court will consider the scope of federal authority and its impact on the balance between national security and individual rights. In Hikma Pharmaceuticals v. Amarin, the Court will decide whether generic drugmakers can face patent liability when marketing products that exclude patented uses, with potential implications for drug pricing and competition. ...